Accord to donate four million tablets to global COVID-19 prophylaxis trial
The enterprise announced it will donate two million hydroxychloroquine tablets and the same of matched placebo to the multi-national COPCOV study.
List view / Grid view
The enterprise announced it will donate two million hydroxychloroquine tablets and the same of matched placebo to the multi-national COPCOV study.
Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests...
A new type of skin patch that administers drugs directly into the bloodstream is being tested as a possible answer to the antibiotic resistance crisis...